Evidence map›Paper›PMID 30210101›Full record

Trial reportInternal medicine (Tokyo, Japan)2019

Differences in Adherence Barriers to Inhaled Medicines between Japanese Patients with Chronic Obstructive Pulmonary Disease and Asthma Evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) Questionnaire.

Takayuki Toyama, Tomotaka Kawayama, Takashi Kinoshita, Yohei Imamura, Makoto Yoshida, Koichiro Takahashi, Kazuhiko Fujii, Ikkou Higashimoto, Tomoaki Hoshino

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Observational
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Status of and strategies for improving adherence to COPD treatment.International journal of chronic obstructive pulmonary disease · 2019
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Takayuki ToyamaDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Tomotaka KawayamaDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Takashi KinoshitaDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Yohei ImamuraDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Makoto YoshidaKyushu Asthma Seminar Investigators, Japan.
Koichiro TakahashiKyushu Asthma Seminar Investigators, Japan.
Kazuhiko FujiiKyushu Asthma Seminar Investigators, Japan.
Ikkou HigashimotoKyushu Asthma Seminar Investigators, Japan.
Tomoaki HoshinoDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective This multicenter, cross-sectional, non-interventional trial aimed to investigate adherence barriers to inhaled medicines when compared with oral medicines in Japanese patients with chronic obstructive pulmonary disease (COPD) and asthma. Methods The self-reporting "Adherence Starts with Knowledge 20" (ASK-20) questionnaire was administered for adherence barriers of inhaled and oral medicines to outpatients with regular clinic attendance. Results Patients with COPD and asthma reported different adherence barriers to inhaled medicines. Independent adherence barriers [odds ratio (95% confidence interval)] to inhaled medicines relative to those for oral medicines among patients with COPD and asthma were those related to item Q8 [ "I know if I am reaching my health goals"; 2.49 (1.39-4.47); p=0.0022] and item Q2 [ "I run out of my medicine because I do not get refills on time"; 2.69 (1.26-5.75); p=0.0127], respectively. Among patients with poor adherence to only inhaled medicines, those with COPD and asthma recognized item Q3 [ "consuming alcohol and taking medicines"; 6.63 (1.27-34.7); p<0.05] and item Q1 [ "forget to take medicines only sometimes"; 4.29 (1.83-10.0); p<0.05], respectively, were recognized as independent adherence barriers to inhaled medicines. The total ASK-20 scores and total barrier counts in patients with poor adherence to inhaled medicines were significantly higher than in those without poor adherence among patients with asthma (p=0.0057) but not those with COPD (p>0.05). Conclusion These results will aid in personalizing education on adherence to inhaled medicines among patients with COPD and asthma.

Indexed as

Drug MonitoringAdministration, InhalationAdministration, OralAdultAgedAsthmaCross-Sectional StudiesFemaleForced Expiratory VolumeHealth Knowledge, Attitudes, PracticeHumansJapanMaleMiddle AgedPatient Education as TopicPulmonary Disease, Chronic ObstructiveRespiratory System Agentsadherence barrierasthmaCOPDinhaled medicine

Identifiers

PMID30210101
PMCPMC6378151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.